Cameroon vs Equatorial Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cameroon
1.8%
in 2024
Equatorial Guinea
2.0%
in 2024
Cameroon rank
14th
Equatorial Guinea rank
12th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cameroon
- Equatorial Guinea
How they compare
Equatorial Guinea currently reports 2.0% against 1.8% in Cameroon, a difference of 0.2%.
That makes Equatorial Guinea's figure about 1.1 times Cameroon's.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Cameroon ranks 14th and Equatorial Guinea ranks 12th of 215 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 2.3% | 0.3% | Equatorial Guinea |
| 2020s | 2.0% | 2.1% | 0.1% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cameroon or Equatorial Guinea?
- Equatorial Guinea, at 2.0% against 1.8% in Cameroon as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cameroon and Equatorial Guinea?
- 0.2%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Cameroon and Equatorial Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Cameroon and Equatorial Guinea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cameroon ranks 14th and Equatorial Guinea ranks 12th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.